Generic Name and Formulations:
Oxazepam 10mg, 15mg, 30mg; caps.
Various generic manufacturers
Indications for Oxazepam:
Mild to moderate: 10–15mg 3–4 times daily. Severe: 15–30mg 3–4 times daily.
Renal, cardiovascular, or liver disease. Change dose gradually. Reevaluate periodically. Aspirin sensitivity (15mg tabs only). Monitor blood counts and liver function. Pregnancy, nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
CNS depression, drowsiness, dizziness, memory impairment, headache, ataxia, paradoxical excitement, hypotension, rash, nausea, edema, slurred speech, jaundice, blood dyscrasias, abuse potential.
Formerly known under the brand names Serax (caps, tabs); Zaxopam (caps).
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma